Berent Prakken (MD, PhD) is a professor of immunology and pediatrics at the Utrecht Medical Center Utrecht, the Netherlands. He is also head of research and education of the Wilhelmina Children’s Hospital. Berent Prakken heads a translational research lab that focuses on regulation of inflammation and biomarker development in human inflammatory diseases. Prakken published over 170 articles (H index 37) in international journals, including Nature Medicine, Lancet, PNAS, J Exp Med, Immunity, JCI and Nature Review journals. He and his group received prestigious national and international awards and grants. The Prakken lab hosted a core facility for the Immune Tolerance Network of the NIH, and is an international expertise centre for biomarkers and the luminex technology. Prakken is editor and associate editor of several journals including the Annals of Rheumatic Diseases and the European Journal of Immunology. Berent Prakken was chair of the standing committee of pediatric rheumatology in EULAR, and member of the PRES council and EULAR executive committee. He is member of the steering committee of UCAN and has set up the first international platform for biological studies in arthritis (UCAN-U, www.ucan-u.org). He is coordinator of EUTRAIN, a EU FP7 Marie Curie Integrated Training Network (www.eutrain-network.eu), and partners in various other EU projects. Prakken serves in various national and international research advisory boards and is member of the Dutch National Health Council (‘Gezondheidsraad’). He was vice-chair of the institutional Ethics Review Board.
Berent Prakken’s personal commitment is to collaboration and training & education. Unconventional thinking and crossing traditional boundaries inspired him and his co-founders to set up the Eureka Institute for Translational Medicine (www.eurekainstitute.org).